Falcone and Stolnik Labs are New Members of the Nanovac Consortium
We have recently become members of the Nanovac Consortium. The Nanovac consortium is a fast growing international network of research groups and SMEs led by the Medway School of Pharmacy, interested in developing nanoconjugates and vaccines in particular - but not exclusively - for the treatment of allergic and inflammatory diseases. We are aiming to attract Horizon 2020 funding to further develop our ideas for innovative treatments.
More information is available here.